cytidine has been researched along with leflunomide in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bartlett, RR; Müller, S; Zeitter, D; Zielinski, T | 1 |
Collins, M; Graves, LM; Huang, M; Mitchell, BS; Wang, Y | 1 |
Collins, M; Graves, LM; Huang, M; Wang, Y | 1 |
3 other study(ies) available for cytidine and leflunomide
Article | Year |
---|---|
Leflunomide, a reversible inhibitor of pyrimidine biosynthesis?
Topics: Cell Division; Cell Line; Cytidine; Humans; Immunosuppressive Agents; Isoxazoles; Kinetics; Leflunomide; Pyrimidines; Uracil Nucleotides; Uridine | 1995 |
A77 1726 induces differentiation of human myeloid leukemia K562 cells by depletion of intracellular CTP pools.
Topics: Aniline Compounds; Anti-Inflammatory Agents, Non-Steroidal; Aspartate Carbamoyltransferase; Carbamoyl-Phosphate Synthase (Glutamine-Hydrolyzing); Cell Cycle Proteins; Cell Differentiation; Cell Division; Crotonates; Cytidine; Cytidine Triphosphate; Dihydroorotase; Drug Interactions; Gene Expression; Glycophorins; Humans; Hydroxybutyrates; Isoxazoles; K562 Cells; Leflunomide; Multienzyme Complexes; Nitriles; Pyrimidines; S Phase; Toluidines; Uridine; Uridine Triphosphate | 2002 |
CPEC induces erythroid differentiation of human myeloid leukemia K562 cells through CTP depletion and p38 MAP kinase.
Topics: Affinity Labels; Carbon-Nitrogen Ligases; Cell Differentiation; Cytidine; Cytidine Triphosphate; Dipyridamole; Enzyme Inhibitors; Equilibrative Nucleoside Transporter 1; Erythroid Precursor Cells; Humans; Isoxazoles; K562 Cells; Leflunomide; Leukemia, Myeloid; p38 Mitogen-Activated Protein Kinases; Phosphodiesterase Inhibitors; Pyrimidines; RNA, Small Interfering; S Phase; Thioinosine | 2004 |